AVE9633 is an anti-CD33 monoclonal antibody-DM4 conjugate.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Eliglustat | The metabolism of Eliglustat can be decreased when combined with AVE9633. |
| Ibrutinib | The metabolism of Ibrutinib can be decreased when combined with AVE9633. |
| Alfentanil | The serum concentration of Alfentanil can be increased when it is combined with AVE9633. |
| Buspirone | The metabolism of Buspirone can be decreased when combined with AVE9633. |
| Carbamazepine | The metabolism of Carbamazepine can be decreased when combined with AVE9633. |
| Cisapride | The serum concentration of Cisapride can be increased when it is combined with AVE9633. |
| Disopyramide | AVE9633 may increase the QTc-prolonging activities of Disopyramide. |
| Estazolam | The serum concentration of Estazolam can be increased when it is combined with AVE9633. |
| Quinine | The serum concentration of Quinine can be increased when it is combined with AVE9633. |
| Quinidine | The serum concentration of Quinidine can be increased when it is combined with AVE9633. |
| Repaglinide | The serum concentration of Repaglinide can be increased when it is combined with AVE9633. |
| Sirolimus | The metabolism of Sirolimus can be decreased when combined with AVE9633. |
| Temsirolimus | The metabolism of Temsirolimus can be decreased when combined with AVE9633. |
| Terfenadine | The serum concentration of Terfenadine can be increased when it is combined with AVE9633. |
| Triazolam | The serum concentration of Triazolam can be increased when it is combined with AVE9633. |
| Cilostazol | The metabolism of Cilostazol can be decreased when combined with AVE9633. |
| Colchicine | The metabolism of Colchicine can be decreased when combined with AVE9633. |
| Iloperidone | The metabolism of Iloperidone can be decreased when combined with AVE9633. |
| Retapamulin | The metabolism of Retapamulin can be decreased when combined with AVE9633. |
| Tofacitinib | The metabolism of Tofacitinib can be decreased when combined with AVE9633. |
| Vardenafil | The metabolism of Vardenafil can be decreased when combined with AVE9633. |
| Eszopiclone | The metabolism of Eszopiclone can be decreased when combined with AVE9633. |
| Zopiclone | The metabolism of Zopiclone can be decreased when combined with AVE9633. |
| Lovastatin | The metabolism of Lovastatin can be decreased when combined with AVE9633. |
| Alfuzosin | The metabolism of Alfuzosin can be decreased when combined with AVE9633. |
| Alprazolam | The serum concentration of Alprazolam can be increased when it is combined with AVE9633. |
| Warfarin | The serum concentration of Warfarin can be increased when it is combined with AVE9633. |
| Acenocoumarol | The serum concentration of Acenocoumarol can be increased when it is combined with AVE9633. |
| (R)-warfarin | The serum concentration of (R)-warfarin can be increased when it is combined with AVE9633. |
| R,S-Warfarin alcohol | The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with AVE9633. |
| S,R-Warfarin alcohol | The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with AVE9633. |
| (S)-Warfarin | The serum concentration of (S)-Warfarin can be increased when it is combined with AVE9633. |
| Midazolam | The serum concentration of Midazolam can be increased when it is combined with AVE9633. |
| Tacrolimus | The serum concentration of Tacrolimus can be increased when it is combined with AVE9633. |
| Telaprevir | The serum concentration of Telaprevir can be increased when it is combined with AVE9633. |
| Chlorotrianisene | Chlorotrianisene may increase the thrombogenic activities of AVE9633. |
| Estrone | Estrone may increase the thrombogenic activities of AVE9633. |
| Dienestrol | Dienestrol may increase the thrombogenic activities of AVE9633. |
| Estriol | Estriol may increase the thrombogenic activities of AVE9633. |
| Quinestrol | Quinestrol may increase the thrombogenic activities of AVE9633. |
| Hexestrol | Hexestrol may increase the thrombogenic activities of AVE9633. |
| Tibolone | Tibolone may increase the thrombogenic activities of AVE9633. |
| Polyestradiol phosphate | Polyestradiol phosphate may increase the thrombogenic activities of AVE9633. |
| Zeranol | Zeranol may increase the thrombogenic activities of AVE9633. |
| Equol | Equol may increase the thrombogenic activities of AVE9633. |
| Promestriene | Promestriene may increase the thrombogenic activities of AVE9633. |
| Methallenestril | Methallenestril may increase the thrombogenic activities of AVE9633. |
| Epimestrol | Epimestrol may increase the thrombogenic activities of AVE9633. |
| Moxestrol | Moxestrol may increase the thrombogenic activities of AVE9633. |
| Biochanin A | Biochanin A may increase the thrombogenic activities of AVE9633. |
| Formononetin | Formononetin may increase the thrombogenic activities of AVE9633. |
| Diethylstilbestrol | Diethylstilbestrol may increase the thrombogenic activities of AVE9633. |
| Conjugated estrogens | Conjugated estrogens may increase the thrombogenic activities of AVE9633. |
| Estradiol | Estradiol may increase the thrombogenic activities of AVE9633. |
| Ethinylestradiol | Ethinylestradiol may increase the thrombogenic activities of AVE9633. |
| Mestranol | Mestranol may increase the thrombogenic activities of AVE9633. |
| Estrone sulfate | Estrone sulfate may increase the thrombogenic activities of AVE9633. |
| Synthetic Conjugated Estrogens, A | Synthetic Conjugated Estrogens, A may increase the thrombogenic activities of AVE9633. |
| Synthetic Conjugated Estrogens, B | Synthetic Conjugated Estrogens, B may increase the thrombogenic activities of AVE9633. |
| Esterified estrogens | Esterified estrogens may increase the thrombogenic activities of AVE9633. |
| Estradiol acetate | Estradiol acetate may increase the thrombogenic activities of AVE9633. |
| Estradiol benzoate | Estradiol benzoate may increase the thrombogenic activities of AVE9633. |
| Estradiol cypionate | Estradiol cypionate may increase the thrombogenic activities of AVE9633. |
| Estradiol valerate | Estradiol valerate may increase the thrombogenic activities of AVE9633. |
| Picosulfuric acid | The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with AVE9633. |
| Vintafolide | The serum concentration of Vintafolide can be increased when it is combined with AVE9633. |
| Vincamine | The serum concentration of Vincamine can be increased when it is combined with AVE9633. |
| Acetyldigitoxin | The serum concentration of Acetyldigitoxin can be increased when it is combined with AVE9633. |
| Deslanoside | The serum concentration of Deslanoside can be increased when it is combined with AVE9633. |
| Ouabain | The serum concentration of Ouabain can be increased when it is combined with AVE9633. |
| Oleandrin | The serum concentration of Oleandrin can be increased when it is combined with AVE9633. |
| Cymarin | The serum concentration of Cymarin can be increased when it is combined with AVE9633. |
| Proscillaridin | The serum concentration of Proscillaridin can be increased when it is combined with AVE9633. |
| Metildigoxin | The serum concentration of Metildigoxin can be increased when it is combined with AVE9633. |
| Lanatoside C | The serum concentration of Lanatoside C can be increased when it is combined with AVE9633. |
| Gitoformate | The serum concentration of Gitoformate can be increased when it is combined with AVE9633. |
| Acetyldigoxin | The serum concentration of Acetyldigoxin can be increased when it is combined with AVE9633. |
| Peruvoside | The serum concentration of Peruvoside can be increased when it is combined with AVE9633. |
| Cyclosporine | The metabolism of Cyclosporine can be decreased when combined with AVE9633. |
| Dicoumarol | The serum concentration of Dicoumarol can be increased when it is combined with AVE9633. |
| Phenindione | The serum concentration of Phenindione can be increased when it is combined with AVE9633. |
| Coumarin | The serum concentration of Coumarin can be increased when it is combined with AVE9633. |
| Tioclomarol | The serum concentration of Tioclomarol can be increased when it is combined with AVE9633. |
| Ethyl biscoumacetate | The serum concentration of Ethyl biscoumacetate can be increased when it is combined with AVE9633. |
| Diphenadione | The serum concentration of Diphenadione can be increased when it is combined with AVE9633. |
| 4-hydroxycoumarin | The serum concentration of 4-hydroxycoumarin can be increased when it is combined with AVE9633. |
| Fluindione | The serum concentration of Fluindione can be increased when it is combined with AVE9633. |
| Clorindione | The serum concentration of Clorindione can be increased when it is combined with AVE9633. |
| Oxtriphylline | The metabolism of Oxtriphylline can be decreased when combined with AVE9633. |
| Doxofylline | The metabolism of Doxofylline can be decreased when combined with AVE9633. |
| Bamifylline | The metabolism of Bamifylline can be decreased when combined with AVE9633. |
| Acefylline | The metabolism of Acefylline can be decreased when combined with AVE9633. |
| Bufylline | The metabolism of Bufylline can be decreased when combined with AVE9633. |
| Fenethylline | The metabolism of Fenethylline can be decreased when combined with AVE9633. |
| Proxyphylline | The metabolism of Proxyphylline can be decreased when combined with AVE9633. |
| Bromotheophylline | The metabolism of Bromotheophylline can be decreased when combined with AVE9633. |
| Pentoxifylline | The metabolism of Pentoxifylline can be decreased when combined with AVE9633. |
| 8-azaguanine | The metabolism of 8-azaguanine can be decreased when combined with AVE9633. |
| 7,9-Dimethylguanine | The metabolism of 7,9-Dimethylguanine can be decreased when combined with AVE9633. |
| Xanthine | The metabolism of Xanthine can be decreased when combined with AVE9633. |